Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after lumpectomy

Data ReadoutpositiveREGENERAPositive

AI Analysis

Summary

Tensive reported positive pivotal 12-month clinical trial data for REGENERA demonstrating efficacy in natural breast reconstruction following lumpectomy.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

pivotal 12-month clinical trial data confirming REGENERA delivers natural breast reconstruction after lumpectomy

Importance:7/10

Sentiment:

0.70

clinical trialbreast reconstructionpivotal study12-month data

Related Companies

$NAII

Read the original article

Published by GlobeNewswire Clinical Studies on July 28, 2026 6:30 AM

Read Original